News & Insights | Adam Gregory

Welcome to Mewburn Ellis Forward, where you can stay up-to-date with our latest news, insights, and features.

Featured posts

28 Sept 2026

UPC Weekly - How early is too early for UPC actions and UPC opt-outs?

UPC Weekly brings you timely, thoughtful and joined-up insight into the evolving landscape of patent litigation at the Unified Patent Court. 2026 Week 39 More...

From pilot lines to supply chains: a view across the battery industry

UPC Weekly - The latest on preliminary injunctions at the UPC – Part 2

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2026

29 May 2026 Read More

Event - From Innovation to Impact: Resolving Pinch Points in Cell and Gene Therapies, 23 July

29 Jul 2025 Read More

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

04 Jul 2025 Read More

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2025

03 Jun 2025 Read More

Crafting IP Strategies for Innovative Biotechs

03 Apr 2025 Read More

In vivo Cell Therapy: Breaking Free of the Chains of Ex Vivo Engineering

19 Mar 2025 Read More

Subscribe to Mewburn Ellis Forward

Receive our latest news, insights and features on all things IP direct to your inbox every month.

Hummingbird Bioscience’s multi-payload ADC technology licensed by Callio Therapeutics

07 Mar 2025 Read More

A Meaty Victory for Impossible Foods

30 Jan 2025 Read More

Mewburn Ellis: top tier firm Legal 500 2025

02 Oct 2024 Read More